Correctness of use of microdosed combination oral contraceptives in young women

Correctness of use of microdosed combination oral contraceptives in young women

The article describes the effective use of a microdosed combined oral contraceptive containing drospirenone in young women. The use of synthetic progestin IV generation due to antiandrogenic and unique antimineralocorticoid effects makes it possible to obtain an additional spectrum of medicinal prop...

Full description

Bibliographic Details
Main Author:	N A Buralkina
Format:	Article
Language:	Russian
Published:	IP Berlin A.V. 2017-08-01
Series:	Гинекология
Subjects:	microdosed combined oral contraceptives drospirenone young women ethinyl estradiol acne body weight
Online Access:	https://gynecology.orscience.ru/2079-5831/article/viewFile/28631/pdf

Similar Items

PREMENSTRUAL SYNDROME: FROM THEORY TO PRACTICE
by: O. V. Yakushevskaya
Published: (2016-12-01)

Prolonged treatment of combined oral contraceptive: a focus on the prevention of inflammatory diseases of the pelvic organs
by: N I Tapilskaya, et al.
Published: (2017-02-01)

Simultaneous total occlusion of two coronary arteries associated with use of drospirenone-ethinyl estradiol (oral contraceptive)
by: Hüsnü Atmaca, et al.
Published: (2018-01-01)

Non-contraceptive effects of microdose folate-containing oral contraceptive in patients of child bearing age
by: T. M. Sokolova, et al.
Published: (2018-09-01)

Clinical behavior of a cohort of adult women with facial acne treated with combined oral contraceptive: ethinylestradiol 20 µg/dienogest 2 mg
by: Palacio-Cardona J, et al.
Published: (2017-11-01)

FIXED PROLONGED REGIME OF COMBINED ORAL CONTRACEPTIVES (COC) INTAKE IN SOLUTION OF CLASSIC CONTRACEPTION ISSUES (LITERATURE REVIEW)
by: V. N. Prilepskaya, et al.
Published: (2017-07-01)

Effectiveness and safety assessment of drospirenone/ethinyl estradiol tablet in treatment of PCOS patients: a single center, prospective, observational study
by: Li Li, et al.
Published: (2020-02-01)

A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial
by: Unnop Jaisamrarn, et al.
Published: (2018-04-01)

Dysmenorrhea: effectiveness and acceptability of treatment with a drug containing 2 mg of chloromadinone acetate and 0.03 mg of ethinyl estradiol
by: V N Prilepskaia, et al.
Published: (2017-06-01)

COMBINED ORAL CONTRACEPTIVES IN TREATMENT OF PATIENTS WITH POLYCYSTIC OVARY SYNDROME
by: M. A. Gevorkyan, et al.
Published: (2016-09-01)

Benefits of using combined oral contraceptive with drospirenone in 24+4 overweight adolescents
by: I V Kuznetsova, et al.
Published: (2014-02-01)

Contraceptive and therapeutic effects of drospirenone-containing hormonal antifertility agent with 24/4 dosage regimen
by: M A Gevorkian, et al.
Published: (2013-06-01)

CONTRACEPTION WITH DROSPIRENONE: EFFECT ON THE BODY WEIGHT AND SOME LIPID METABOLISM INDICATORS
by: A. A. Smetnik
Published: (2016-12-01)

Contraception for women with epilepsy: counseling, choices, and concerns
by: Reimers A
Published: (2016-04-01)

Comparison of risks of thromboembolism of drospirenone-containing and nondrospirenone -containing combined oral contraceptive use: A meta-analysis
by: Wan-Lin Zhang, et al.
Published: (2021-01-01)

Validated HPTLC method for simultaneous estimation of ethinyl estradiol and drospirenone in bulk drug and formulation
by: Bhusari Vidhya K., et al.
Published: (2012-06-01)

Hormonal contraception in women of reproductive age: endocrinological aspects
by: Tamara V Ovsyannikova, et al.
Published: (2019-02-01)

Hormonal contraception as a method of social adaptation of women in modern society
by: Tatyana Yu Pestrikova, et al.
Published: (2019-06-01)

Porphyria cutanea tarda associated with HFE C282Y homozygosity, iron overload, and use of a contraceptive vaginal ring
by: James C. Barton, et al.
Published: (2016-02-01)

An open-label, two-period comparative study on pharmacokinetics and safety of a combined ethinylestradiol/gestodene transdermal contraceptive patch
by: Zhang C, et al.
Published: (2017-03-01)

Oral contraceptive therapy increases oxidative stress in pre-menopausal women
by: Jui Tung Chen, et al.
Published: (2012-01-01)

50 years of hormonal contraception – time to find out, what it does to our brain
by: Belinda ePletzer, et al.
Published: (2014-08-01)

Personal selection of hormonal contraception
by: I V Kuznetsova
Published: (2017-08-01)

COMPARATIVE ANALYSIS OF REQUIREMENTS FOR QUALITY CONTROL OF ETHINYL ESTRADIOL AND LEVONORGESTREL CONTAINING MEDICINAL PRODUCTS
by: V. I. Seredenko, et al.
Published: (2018-03-01)

Personalized approach of a hormonal contraceptive for patients requiring control of body weight (review)
by: T Yu Pestrikova, et al.
Published: (2018-06-01)

ORAL HORMONAL CONTRACEPTION - THE INFLUENCE ON HUMAN GENOME AND LIPID STATUS
by: Dragan Loncar
Published: (2007-01-01)

Contraceptive options for women with premenstrual dysphoric disorder: current insights and a narrative review
by: Lete I, et al.
Published: (2016-08-01)

Comparison of Drospirenone- with Cyproterone Acetate-Containing Oral Contraceptives, Combined with Metformin and Lifestyle Modifications in Women with Polycystic Ovary Syndrome and Metabolic Disorders: A Prospective Randomized Control Trial
by: Qiu-Yi Wang, et al.
Published: (2016-01-01)

NON-DEVELOPING PREGNANCY. THE ROLE OF HORMONAL CONTRACEPTION IN REHABILITATION TREATMENT
by: G. B. Dikke
Published: (2016-09-01)

Vaginal hormonal ring: a modern method for prolonged contraception
by: A. Z. Khashukoeva, et al.
Published: (2020-04-01)

Combined Oral Contraceptive Use in Young Stroke Etiology: A Case Report and Literature Review
by: Hasan Hüseyin Karadeli, et al.
Published: (2021-06-01)

The personalized approach to choosing a contraceptive: weighing the pros and cons
by: Yu E Dobrokhotova, et al.
Published: (2017-06-01)

Effects of Ethinyl Estradiol in Combined Oral Contraceptives on Cell Proliferation and Apoptosis in Ectopic Endometrial Tissue: A Randomized Controlled Study
by: Areepan Sophonsritsuk, et al.
Published: (2021-04-01)

Bleeding Pattern and Management of Unexpected Bleeding/Spotting with an Extended Regimen of a Combination of Ethinylestradiol 20 mcg and Drospirenone 3 mg
by: Bonassi Machado R, et al.
Published: (2020-03-01)

FREQUENCY AND METHODS OF CORRECTION OF MAGNESIUM DEFICIENCY IN YOUNG WOMEN OF REPRODUCTIVE AGE AT TAKING COMBINED ORAL CONTRACEPTIVE PILLS
by: I. S. Vyatkina, et al.
Published: (2014-04-01)

Effect of a new oral contraceptive on metabolism and the cardiovascular system
by: E. V. Yenkova
Published: (2015-12-01)

Dose and delivery method impact cognitive outcome of Ethinyl Estradiol administration in the surgically menopausal rat
Published: (2012)

Therapeutic non-contraceptive properties of the drug containing ethinylestradiol 0.03 mg and drospirenone 3 mg
by: Natalia V Artymuk, et al.
Published: (2019-10-01)

COC compliance – accessible improvement in the quality of life
by: A L Tikhomirov
Published: (2013-08-01)

Influence of Oral Contraceptives on Bone Adaptations to Isokinetic Strength Training in Young Women
by: Selmon, Serah Elizabeth
Published: (2011)